publication venue for
- Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma.. 37:154-163. 2022
- Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients.. 37:1006-1017. 2022
- Ixazomib, lenalidomide and dexamethasone consolidation with randomized ixazomib or lenalidomide maintenance after autologous transplant in newly diagnosed multiple myeloma.. 36:2917-2921. 2022
- Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length.. 36:221-224. 2021
- Simplified frailty assessment tools: are we really capturing frailty or something else?. 34:1967-1969. 2020
- Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60-75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study.. 33:2599-2609. 2019
- Ninety-minute daratumumab infusion is safe in multiple myeloma.. 32:2495-2518. 2018
- Citrullination of histone H3 drives IL-6 production by bone marrow mesenchymal stem cells in MGUS and multiple myeloma.. 31:373-381. 2016
- Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length 2021
- Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma. 2019
- Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients. 2017